Capsules Féminithé
Capsules Féminithé, licence 80047288: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Clef des Champs Inc.
- NPN or DIN-HM
- 80047288
- Status
- Active licence
- Licence date
- 17 December 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zingiber officinale Source : Rhizome | 39.0 mg | Not calculated |
| Rubus idaeus Source : Feuille | 39.0 mg | Not calculated |
| Cnicus benedictus Source : Fleurs et feuilles | 39.0 mg | Not calculated |
| Achillea millefolium Source : Fleur | 39.0 mg | Not calculated |
| Chamaelirium luteum Source : Racine et rhizome | 39.0 mg | Not calculated |
| Viburnum opulus Source : Écorce (rameau) | 39.0 mg | Not calculated |
| Capsicum annuum Source : Fruit | 10.0 mg | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille | 39.0 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropyl methylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescents | minimum: 14.0 Année(s) ; maximum: 18.0 Année(s) | 2.0 Capsule | minimum: 1.0 Jour(s) ; maximum: 2.0 Jour(s) |
| Adultes | Not specified | 3.0 Capsule | minimum: 1.0 Jour(s) ; maximum: 2.0 Jour(s) |
Uses authorised in Canada
Utilisé traditionellement en herboristerie occidentale comme tonique utérin.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de la santé si les symptômes persistent, s'aggravent ou si de nouveaux symptômes apparaissent. Consulter un praticien de la santé avant d'utiliser avec des médicaments d'ordonnance. Consulter un praticien de la santé en cas d'inflammation ou ulcère gastrique. Ne pas utiliser si vous souffrez de maladies graves ou prendez des produits contenant des diurétiques.
- Contre-indications
Ne pas utiliser en cas de grossesse ou d'allaitement. Ne pas utiliser en cas d'allergies à la famille des astéracées.
Source
Official Health Canada record, licence 80047288
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.